USA flag logo/image

An Official Website of the United States Government

VACCINE AGAINST HAEMOPHILUS INFLUENZAE TYPE B

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
11095
Program Year/Program:
1989 / SBIR
Agency Tracking Number:
11095
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Synergen Inc
1885 33rd St Boulder, CO 80301
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1989
Title: VACCINE AGAINST HAEMOPHILUS INFLUENZAE TYPE B
Agency: HHS
Contract: N/A
Award Amount: $49,766.00
 

Abstract:

THIS RESEARCH WILL LEAD TO THE DEVELOPMENT OF A VACCINE THAT CAN BE USED TO PROTECT YOUNG CHILDREN AGAINST INFECTIONS CAUSED BY HAEMOPHILUS INFLUENZAE TYPE B (HIB). THE VACCINE WILL BE BASED ON THE PILI THAT FACILITATE THE ORGANISM'S ADHERENCE TO THE NASOPHARYNGEAL EPITHELIUM. ANTIBODIES PRODUCED IN RESPONSE TO THE VACCINE WILL BIND TO HIB PILI, PREVENTING ADHERENCE AND COLONIZATION, AND THEREBY LOWERING THE INCIDENCE OF SYSTEMIC INFECTIONS CAUSED BY THE ORGANISM. IN THE PHASE I FEASIBILITY STUDY, THE ABILITY OF PILI-SPECIFIC ANTIBODIES TO BLOCK ADHERENCE OF HETEROLOGOUS HIB STRAINS TO EPITHELIAL CELLS IN VITRO WILL BE DETERMINED. THE MAIN OBJECTIVES OF PHASE II WILL BE TO DETERMINE: (1) WHETHER PASSIVELY ADMINISTERED ANTIBODIES TO PILI REDUCE OR PREVENT COLONIZATION OF MODEL ANIMALS AND (2) THE DOSE AND ROUTE OF ADMINISTRATION NEEDED TO STIMULATE THE FORMATION OF PILI-SPECIFIC ANTIBODIES IN THE NASOPHARYNX OF IMMUNIZED ANIMALS. THIS RESEARCH PROVIDES A BASIS FOR DEVELOPING VACCINES AGAINST HIB AND OTHER PATHOGENS THAT ADHERE TO SURFACES BY MEANS OF PILI OR ADHESION PROTEINS.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Synergen Inc
1885 33rd St Boulder, CO 80301

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No